vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and GYRE THERAPEUTICS, INC. (GYRE). Click either name above to swap in a different company.
GYRE THERAPEUTICS, INC. is the larger business by last-quarter revenue ($37.2M vs $25.8M, roughly 1.4× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs -3.7%, a 43.0% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs 17.5%). First Bancorp, Inc produced more free cash flow last quarter ($34.6M vs $-5.8M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs 17.0%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
FNLC vs GYRE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $37.2M |
| Net Profit | $10.2M | $-1.4M |
| Gross Margin | — | 95.3% |
| Operating Margin | 48.1% | 0.3% |
| Net Margin | 39.4% | -3.7% |
| Revenue YoY | 17.5% | 33.4% |
| Net Profit YoY | 39.7% | -340.1% |
| EPS (diluted) | $0.91 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | $37.2M | ||
| Q3 25 | $24.5M | $30.6M | ||
| Q2 25 | $22.5M | $26.8M | ||
| Q1 25 | $21.8M | $22.1M | ||
| Q4 24 | $22.0M | $27.9M | ||
| Q3 24 | $20.5M | $25.5M | ||
| Q2 24 | $19.2M | $25.2M | ||
| Q1 24 | $18.5M | $27.2M |
| Q4 25 | $10.2M | $-1.4M | ||
| Q3 25 | $9.1M | $5.9M | ||
| Q2 25 | $8.1M | $1.6M | ||
| Q1 25 | $7.1M | $3.7M | ||
| Q4 24 | $7.3M | $569.0K | ||
| Q3 24 | $7.6M | $2.9M | ||
| Q2 24 | $6.2M | $4.5M | ||
| Q1 24 | $6.0M | $9.9M |
| Q4 25 | — | 95.3% | ||
| Q3 25 | — | 94.7% | ||
| Q2 25 | — | 95.7% | ||
| Q1 25 | — | 95.9% | ||
| Q4 24 | — | 95.8% | ||
| Q3 24 | — | 96.2% | ||
| Q2 24 | — | 96.9% | ||
| Q1 24 | — | 96.4% |
| Q4 25 | 48.1% | 0.3% | ||
| Q3 25 | 45.2% | 22.7% | ||
| Q2 25 | 43.7% | 8.1% | ||
| Q1 25 | 39.3% | 10.3% | ||
| Q4 24 | 39.5% | 2.4% | ||
| Q3 24 | 44.6% | 16.6% | ||
| Q2 24 | 38.8% | 12.7% | ||
| Q1 24 | 39.3% | 29.7% |
| Q4 25 | 39.4% | -3.7% | ||
| Q3 25 | 37.0% | 19.4% | ||
| Q2 25 | 35.8% | 5.9% | ||
| Q1 25 | 32.5% | 16.9% | ||
| Q4 24 | 33.1% | 2.0% | ||
| Q3 24 | 36.9% | 11.2% | ||
| Q2 24 | 32.1% | 18.0% | ||
| Q1 24 | 32.5% | 36.6% |
| Q4 25 | $0.91 | $-0.01 | ||
| Q3 25 | $0.81 | $0.03 | ||
| Q2 25 | $0.72 | $0.00 | ||
| Q1 25 | $0.63 | $0.00 | ||
| Q4 24 | $0.66 | $0.00 | ||
| Q3 24 | $0.68 | $0.01 | ||
| Q2 24 | $0.55 | $0.01 | ||
| Q1 24 | $0.54 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $52.4M |
| Total DebtLower is stronger | $95.5M | — |
| Stockholders' EquityBook value | $283.1M | $106.0M |
| Total Assets | $3.2B | $166.1M |
| Debt / EquityLower = less leverage | 0.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $52.4M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $54.4M | ||
| Q1 25 | — | $29.9M | ||
| Q4 24 | — | $26.7M | ||
| Q3 24 | — | $25.1M | ||
| Q2 24 | — | $25.1M | ||
| Q1 24 | — | $37.4M |
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $95.0M | — | ||
| Q2 24 | $70.0M | — | ||
| Q1 24 | $70.0M | — |
| Q4 25 | $283.1M | $106.0M | ||
| Q3 25 | $274.6M | $101.9M | ||
| Q2 25 | $265.5M | $92.0M | ||
| Q1 25 | $259.7M | $68.1M | ||
| Q4 24 | $252.5M | $63.3M | ||
| Q3 24 | $256.8M | $63.2M | ||
| Q2 24 | $244.7M | $60.4M | ||
| Q1 24 | $242.6M | $56.6M |
| Q4 25 | $3.2B | $166.1M | ||
| Q3 25 | $3.2B | $159.4M | ||
| Q2 25 | $3.2B | $152.6M | ||
| Q1 25 | $3.2B | $129.8M | ||
| Q4 24 | $3.2B | $125.4M | ||
| Q3 24 | $3.1B | $125.2M | ||
| Q2 24 | $3.1B | $120.9M | ||
| Q1 24 | $3.0B | $122.0M |
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $-5.6M |
| Free Cash FlowOCF − Capex | $34.6M | $-5.8M |
| FCF MarginFCF / Revenue | 133.9% | -15.5% |
| Capex IntensityCapex / Revenue | 12.5% | 0.4% |
| Cash ConversionOCF / Net Profit | 3.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $-180.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | $-5.6M | ||
| Q3 25 | $12.9M | $4.7M | ||
| Q2 25 | $7.4M | $2.1M | ||
| Q1 25 | $2.2M | $-129.0K | ||
| Q4 24 | $26.0M | $-2.8M | ||
| Q3 24 | $9.8M | $1.7M | ||
| Q2 24 | $6.4M | $-5.5M | ||
| Q1 24 | $-1.5M | $2.9M |
| Q4 25 | $34.6M | $-5.8M | ||
| Q3 25 | $12.6M | $4.0M | ||
| Q2 25 | $7.2M | $1.8M | ||
| Q1 25 | $828.0K | $-251.0K | ||
| Q4 24 | $24.6M | $-2.8M | ||
| Q3 24 | $9.6M | $1.0M | ||
| Q2 24 | $6.3M | $-6.9M | ||
| Q1 24 | $-1.8M | $2.7M |
| Q4 25 | 133.9% | -15.5% | ||
| Q3 25 | 51.4% | 13.1% | ||
| Q2 25 | 32.1% | 6.8% | ||
| Q1 25 | 3.8% | -1.1% | ||
| Q4 24 | 111.7% | -10.1% | ||
| Q3 24 | 47.0% | 4.1% | ||
| Q2 24 | 32.9% | -27.5% | ||
| Q1 24 | -9.8% | 9.8% |
| Q4 25 | 12.5% | 0.4% | ||
| Q3 25 | 1.2% | 2.2% | ||
| Q2 25 | 0.6% | 1.0% | ||
| Q1 25 | 6.2% | 0.6% | ||
| Q4 24 | 6.7% | 0.2% | ||
| Q3 24 | 0.5% | 2.7% | ||
| Q2 24 | 0.3% | 5.8% | ||
| Q1 24 | 1.8% | 0.9% |
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | 0.79× | ||
| Q2 25 | 0.91× | 1.32× | ||
| Q1 25 | 0.31× | -0.03× | ||
| Q4 24 | 3.58× | -4.85× | ||
| Q3 24 | 1.29× | 0.60× | ||
| Q2 24 | 1.03× | -1.21× | ||
| Q1 24 | -0.25× | 0.29× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
